位置:首页 > 蛋白库 > TXLNA_HUMAN
TXLNA_HUMAN
ID   TXLNA_HUMAN             Reviewed;         546 AA.
AC   P40222; D3DPP6; Q5TFJ6; Q66K62; Q86T54; Q86T85; Q86T86; Q86Y86; Q86YW3;
AC   Q8N2Y3;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   09-NOV-2004, sequence version 3.
DT   03-AUG-2022, entry version 186.
DE   RecName: Full=Alpha-taxilin;
GN   Name=TXLNA; Synonyms=TXLN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH SYNTAXIN, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=12558796; DOI=10.1046/j.1365-2443.2003.00612.x;
RA   Nogami S., Satoh S., Nakano M., Shimizu H., Fukushima H., Maruyama A.,
RA   Terano A., Shirataki H.;
RT   "Taxilin; a novel syntaxin-binding protein that is involved in Ca2+-
RT   dependent exocytosis in neuroendocrine cells.";
RL   Genes Cells 8:17-28(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle, and Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 234-546.
RX   PubMed=8327514; DOI=10.1073/pnas.90.13.6330;
RA   Ambrus J.L. Jr., Pippin J., Joseph A., Xu C., Blumenthal D., Tamayo A.,
RA   Claypool K., McCourt D., Srikiatchatochorn A., Ford R.J.;
RT   "Identification of a cDNA for a human high-molecular-weight B-cell growth
RT   factor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:6330-6334(1993).
RN   [7]
RP   ERRATUM OF PUBMED:8327514.
RX   PubMed=8755619; DOI=10.1073/pnas.93.15.8154-b;
RA   Ambrus J.L. Jr., Pippin J., Joseph A., Xu C., Blumenthal D., Tamayo A.,
RA   Claypool K., McCourt D., Srikiatchatochorn A., Ford R.J.;
RL   Proc. Natl. Acad. Sci. U.S.A. 93:8154-8154(1996).
RN   [8]
RP   INTERACTION WITH STX1A; STX3A AND STX4A.
RX   PubMed=14623251; DOI=10.1016/j.bbrc.2003.10.069;
RA   Nogami S., Satoh S., Nakano M., Terano A., Shirataki H.;
RT   "Interaction of taxilin with syntaxin which does not form the SNARE
RT   complex.";
RL   Biochem. Biophys. Res. Commun. 311:797-802(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72 AND SER-515, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May be involved in intracellular vesicle traffic and
CC       potentially in calcium-dependent exocytosis in neuroendocrine cells.
CC   -!- SUBUNIT: Binds to the C-terminal coiled coil region of syntaxin family
CC       members STX1A, STX3A and STX4A, but not when these proteins are
CC       complexed with SNAP25, VAMP2 or STXBP1, suggesting that it interacts
CC       with syntaxins that do not form the SNARE complex.
CC       {ECO:0000269|PubMed:12558796, ECO:0000269|PubMed:14623251}.
CC   -!- INTERACTION:
CC       P40222; Q9Y2T1: AXIN2; NbExp=3; IntAct=EBI-359793, EBI-4400025;
CC       P40222; Q9NQY0: BIN3; NbExp=3; IntAct=EBI-359793, EBI-2653038;
CC       P40222; Q5PSV4: BRMS1L; NbExp=3; IntAct=EBI-359793, EBI-5666615;
CC       P40222; P20290: BTF3; NbExp=3; IntAct=EBI-359793, EBI-1054687;
CC       P40222; Q96K17: BTF3L4; NbExp=6; IntAct=EBI-359793, EBI-6137496;
CC       P40222; Q8NA61: CBY2; NbExp=3; IntAct=EBI-359793, EBI-741724;
CC       P40222; Q8NA61-2: CBY2; NbExp=3; IntAct=EBI-359793, EBI-11524851;
CC       P40222; Q8NEF3-2: CCDC112; NbExp=3; IntAct=EBI-359793, EBI-12095166;
CC       P40222; Q96JN2-2: CCDC136; NbExp=5; IntAct=EBI-359793, EBI-10171416;
CC       P40222; Q8IYE0: CCDC146; NbExp=3; IntAct=EBI-359793, EBI-10749669;
CC       P40222; A0A1B0GWI1: CCDC196; NbExp=5; IntAct=EBI-359793, EBI-10181422;
CC       P40222; Q2TAC2-2: CCDC57; NbExp=3; IntAct=EBI-359793, EBI-10961624;
CC       P40222; Q8TD31-3: CCHCR1; NbExp=6; IntAct=EBI-359793, EBI-10175300;
CC       P40222; Q99459: CDC5L; NbExp=3; IntAct=EBI-359793, EBI-374880;
CC       P40222; Q01850: CDR2; NbExp=7; IntAct=EBI-359793, EBI-1181367;
CC       P40222; Q9C0F1: CEP44; NbExp=6; IntAct=EBI-359793, EBI-744115;
CC       P40222; Q86XR8-3: CEP57; NbExp=3; IntAct=EBI-359793, EBI-11752486;
CC       P40222; Q8IYX8: CEP57L1; NbExp=3; IntAct=EBI-359793, EBI-1104570;
CC       P40222; Q8IYX8-2: CEP57L1; NbExp=3; IntAct=EBI-359793, EBI-10181988;
CC       P40222; Q96MT8: CEP63; NbExp=4; IntAct=EBI-359793, EBI-741977;
CC       P40222; Q96M91: CFAP53; NbExp=3; IntAct=EBI-359793, EBI-742422;
CC       P40222; Q05D60: DEUP1; NbExp=11; IntAct=EBI-359793, EBI-748597;
CC       P40222; Q9NPF5: DMAP1; NbExp=3; IntAct=EBI-359793, EBI-399105;
CC       P40222; O60941: DTNB; NbExp=5; IntAct=EBI-359793, EBI-740402;
CC       P40222; O60941-5: DTNB; NbExp=3; IntAct=EBI-359793, EBI-11984733;
CC       P40222; Q9NRA8: EIF4ENIF1; NbExp=3; IntAct=EBI-359793, EBI-301024;
CC       P40222; O95208-2: EPN2; NbExp=3; IntAct=EBI-359793, EBI-12135243;
CC       P40222; Q8TBF8: FAM81A; NbExp=3; IntAct=EBI-359793, EBI-11993062;
CC       P40222; Q8IZU1: FAM9A; NbExp=3; IntAct=EBI-359793, EBI-8468186;
CC       P40222; O95995: GAS8; NbExp=3; IntAct=EBI-359793, EBI-1052570;
CC       P40222; Q08379: GOLGA2; NbExp=3; IntAct=EBI-359793, EBI-618309;
CC       P40222; Q9NYA3: GOLGA6A; NbExp=3; IntAct=EBI-359793, EBI-11163335;
CC       P40222; Q9H8Y8: GORASP2; NbExp=7; IntAct=EBI-359793, EBI-739467;
CC       P40222; Q68CZ6: HAUS3; NbExp=9; IntAct=EBI-359793, EBI-2558217;
CC       P40222; Q9NX55: HYPK; NbExp=6; IntAct=EBI-359793, EBI-1048743;
CC       P40222; Q63ZY3: KANK2; NbExp=6; IntAct=EBI-359793, EBI-2556193;
CC       P40222; Q86T90: KIAA1328; NbExp=3; IntAct=EBI-359793, EBI-3437878;
CC       P40222; A1A4E9: KRT13; NbExp=3; IntAct=EBI-359793, EBI-10171552;
CC       P40222; P19012: KRT15; NbExp=6; IntAct=EBI-359793, EBI-739566;
CC       P40222; P35900: KRT20; NbExp=6; IntAct=EBI-359793, EBI-742094;
CC       P40222; Q2M2I5: KRT24; NbExp=3; IntAct=EBI-359793, EBI-2952736;
CC       P40222; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-359793, EBI-3044087;
CC       P40222; Q15323: KRT31; NbExp=6; IntAct=EBI-359793, EBI-948001;
CC       P40222; O76011: KRT34; NbExp=3; IntAct=EBI-359793, EBI-1047093;
CC       P40222; Q92764: KRT35; NbExp=3; IntAct=EBI-359793, EBI-1058674;
CC       P40222; O76013-2: KRT36; NbExp=3; IntAct=EBI-359793, EBI-11958506;
CC       P40222; O76015: KRT38; NbExp=6; IntAct=EBI-359793, EBI-1047263;
CC       P40222; Q6A162: KRT40; NbExp=6; IntAct=EBI-359793, EBI-10171697;
CC       P40222; O95678: KRT75; NbExp=3; IntAct=EBI-359793, EBI-2949715;
CC       P40222; Q86VQ0: LCA5; NbExp=3; IntAct=EBI-359793, EBI-6658186;
CC       P40222; Q9Y250: LZTS1; NbExp=3; IntAct=EBI-359793, EBI-1216080;
CC       P40222; Q9NS73-5: MBIP; NbExp=3; IntAct=EBI-359793, EBI-10182361;
CC       P40222; P23508: MCC; NbExp=3; IntAct=EBI-359793, EBI-307531;
CC       P40222; Q9NPJ6: MED4; NbExp=8; IntAct=EBI-359793, EBI-394607;
CC       P40222; P50221: MEOX1; NbExp=3; IntAct=EBI-359793, EBI-2864512;
CC       P40222; P50222: MEOX2; NbExp=3; IntAct=EBI-359793, EBI-748397;
CC       P40222; Q9NYP9: MIS18A; NbExp=4; IntAct=EBI-359793, EBI-1104552;
CC       P40222; Q13765: NACA; NbExp=2; IntAct=EBI-359793, EBI-712216;
CC       P40222; O14777: NDC80; NbExp=7; IntAct=EBI-359793, EBI-715849;
CC       P40222; Q6ZUT1: NKAPD1; NbExp=3; IntAct=EBI-359793, EBI-3920396;
CC       P40222; Q13287: NMI; NbExp=9; IntAct=EBI-359793, EBI-372942;
CC       P40222; Q96MF7: NSMCE2; NbExp=6; IntAct=EBI-359793, EBI-2557388;
CC       P40222; P37198: NUP62; NbExp=8; IntAct=EBI-359793, EBI-347978;
CC       P40222; Q13516: OLIG2; NbExp=3; IntAct=EBI-359793, EBI-3914525;
CC       P40222; O75928-2: PIAS2; NbExp=3; IntAct=EBI-359793, EBI-348567;
CC       P40222; Q13136: PPFIA1; NbExp=5; IntAct=EBI-359793, EBI-745426;
CC       P40222; Q96KQ4: PPP1R13B; NbExp=3; IntAct=EBI-359793, EBI-1105153;
CC       P40222; O43395: PRPF3; NbExp=3; IntAct=EBI-359793, EBI-744322;
CC       P40222; Q8NHQ8-2: RASSF8; NbExp=3; IntAct=EBI-359793, EBI-10976415;
CC       P40222; Q9P2K3: RCOR3; NbExp=3; IntAct=EBI-359793, EBI-743428;
CC       P40222; Q6NUQ1: RINT1; NbExp=6; IntAct=EBI-359793, EBI-726876;
CC       P40222; Q9BRV8: SIKE1; NbExp=3; IntAct=EBI-359793, EBI-1773646;
CC       P40222; Q969G3: SMARCE1; NbExp=3; IntAct=EBI-359793, EBI-455078;
CC       P40222; Q96H20: SNF8; NbExp=3; IntAct=EBI-359793, EBI-747719;
CC       P40222; O60504: SORBS3; NbExp=3; IntAct=EBI-359793, EBI-741237;
CC       P40222; Q8WXA9: SREK1; NbExp=3; IntAct=EBI-359793, EBI-1044237;
CC       P40222; Q93045: STMN2; NbExp=4; IntAct=EBI-359793, EBI-714194;
CC       P40222; Q16623: STX1A; NbExp=4; IntAct=EBI-359793, EBI-712466;
CC       P40222; P61266: STX1B; NbExp=3; IntAct=EBI-359793, EBI-9071709;
CC       P40222; Q86TI0: TBC1D1; NbExp=3; IntAct=EBI-359793, EBI-1644036;
CC       P40222; Q9UHD2: TBK1; NbExp=6; IntAct=EBI-359793, EBI-356402;
CC       P40222; P56279: TCL1A; NbExp=6; IntAct=EBI-359793, EBI-749995;
CC       P40222; Q9UBB9: TFIP11; NbExp=8; IntAct=EBI-359793, EBI-1105213;
CC       P40222; Q15025: TNIP1; NbExp=6; IntAct=EBI-359793, EBI-357849;
CC       P40222; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-359793, EBI-11952721;
CC       P40222; Q13625-3: TP53BP2; NbExp=3; IntAct=EBI-359793, EBI-10175039;
CC       P40222; Q6PID6: TTC33; NbExp=6; IntAct=EBI-359793, EBI-2555404;
CC       P40222; Q8N3L3: TXLNB; NbExp=11; IntAct=EBI-359793, EBI-6116822;
CC       P40222; Q8N6Y0: USHBP1; NbExp=6; IntAct=EBI-359793, EBI-739895;
CC       P40222; Q5TAP6: UTP14C; NbExp=3; IntAct=EBI-359793, EBI-11737646;
CC       P40222; Q8N1B4: VPS52; NbExp=6; IntAct=EBI-359793, EBI-2799833;
CC       P40222; Q9Y3C0: WASHC3; NbExp=8; IntAct=EBI-359793, EBI-712969;
CC       P40222; Q9QYP6: Azi2; Xeno; NbExp=2; IntAct=EBI-359793, EBI-6115874;
CC   -!- TISSUE SPECIFICITY: Ubiquitous, with much higher expression in heart,
CC       kidney, liver and pancreas. {ECO:0000269|PubMed:12558796}.
CC   -!- SIMILARITY: Belongs to the taxilin family. {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a high molecular weight
CC       interleukin (IL-14 or IL14). {ECO:0000305|PubMed:8327514}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH46565.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF516206; AAO42465.1; -; mRNA.
DR   EMBL; AL832636; CAD89951.1; -; mRNA.
DR   EMBL; AL832637; CAD89952.1; -; mRNA.
DR   EMBL; AL832338; CAD91138.1; -; mRNA.
DR   EMBL; AL049795; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07565.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07566.1; -; Genomic_DNA.
DR   EMBL; BC029686; AAH29686.1; -; mRNA.
DR   EMBL; BC046565; AAH46565.1; ALT_INIT; mRNA.
DR   EMBL; BC080578; AAH80578.1; -; mRNA.
DR   EMBL; BC103823; AAI03824.1; -; mRNA.
DR   EMBL; BC103824; AAI03825.1; -; mRNA.
DR   EMBL; L15344; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS353.1; -.
DR   PIR; A48203; A48203.
DR   RefSeq; NP_787048.1; NM_175852.3.
DR   RefSeq; XP_016856051.1; XM_017000562.1.
DR   AlphaFoldDB; P40222; -.
DR   SMR; P40222; -.
DR   BioGRID; 128297; 204.
DR   CORUM; P40222; -.
DR   DIP; DIP-27612N; -.
DR   IntAct; P40222; 138.
DR   MINT; P40222; -.
DR   STRING; 9606.ENSP00000362711; -.
DR   GlyGen; P40222; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P40222; -.
DR   MetOSite; P40222; -.
DR   PhosphoSitePlus; P40222; -.
DR   SwissPalm; P40222; -.
DR   BioMuta; TXLNA; -.
DR   DMDM; 55584162; -.
DR   EPD; P40222; -.
DR   jPOST; P40222; -.
DR   MassIVE; P40222; -.
DR   MaxQB; P40222; -.
DR   PaxDb; P40222; -.
DR   PeptideAtlas; P40222; -.
DR   PRIDE; P40222; -.
DR   ProteomicsDB; 55349; -.
DR   Antibodypedia; 31239; 154 antibodies from 29 providers.
DR   DNASU; 200081; -.
DR   Ensembl; ENST00000373609.1; ENSP00000362711.1; ENSG00000084652.16.
DR   Ensembl; ENST00000373610.8; ENSP00000362712.3; ENSG00000084652.16.
DR   GeneID; 200081; -.
DR   KEGG; hsa:200081; -.
DR   MANE-Select; ENST00000373610.8; ENSP00000362712.3; NM_175852.4; NP_787048.1.
DR   UCSC; uc001bui.4; human.
DR   CTD; 200081; -.
DR   DisGeNET; 200081; -.
DR   GeneCards; TXLNA; -.
DR   HGNC; HGNC:30685; TXLNA.
DR   HPA; ENSG00000084652; Low tissue specificity.
DR   MIM; 608676; gene.
DR   neXtProt; NX_P40222; -.
DR   OpenTargets; ENSG00000084652; -.
DR   PharmGKB; PA142670668; -.
DR   VEuPathDB; HostDB:ENSG00000084652; -.
DR   eggNOG; KOG1850; Eukaryota.
DR   GeneTree; ENSGT00940000158303; -.
DR   HOGENOM; CLU_025501_3_0_1; -.
DR   InParanoid; P40222; -.
DR   OMA; VTEAPCC; -.
DR   OrthoDB; 904532at2759; -.
DR   PhylomeDB; P40222; -.
DR   TreeFam; TF318595; -.
DR   PathwayCommons; P40222; -.
DR   Reactome; R-HSA-449836; Other interleukin signaling.
DR   SignaLink; P40222; -.
DR   BioGRID-ORCS; 200081; 19 hits in 1082 CRISPR screens.
DR   ChiTaRS; TXLNA; human.
DR   GeneWiki; TXLNA; -.
DR   GenomeRNAi; 200081; -.
DR   Pharos; P40222; Tbio.
DR   PRO; PR:P40222; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P40222; protein.
DR   Bgee; ENSG00000084652; Expressed in stromal cell of endometrium and 180 other tissues.
DR   Genevisible; P40222; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0019905; F:syntaxin binding; IEA:InterPro.
DR   GO; GO:0042113; P:B cell activation; IEA:Ensembl.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   InterPro; IPR026183; Taxilin_fam.
DR   PANTHER; PTHR16127; PTHR16127; 1.
DR   Pfam; PF09728; Taxilin; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Exocytosis; Phosphoprotein; Reference proteome.
FT   CHAIN           1..546
FT                   /note="Alpha-taxilin"
FT                   /id="PRO_0000189421"
FT   REGION          1..170
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          482..546
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          186..491
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        136..169
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        529..546
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         72
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         515
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   CONFLICT        12
FT                   /note="K -> Q (in Ref. 2; CAD89951)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        194
FT                   /note="K -> R (in Ref. 2; CAD89952)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        228
FT                   /note="R -> C (in Ref. 5; AAH80578)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        249..250
FT                   /note="QR -> HG (in Ref. 6)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        278
FT                   /note="Q -> L (in Ref. 2; CAD89952)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        368
FT                   /note="E -> A (in Ref. 2; CAD89952)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        412
FT                   /note="K -> E (in Ref. 2; CAD89951)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        530
FT                   /note="T -> A (in Ref. 2; CAD91138)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   546 AA;  61891 MW;  698CD74F78897DF6 CRC64;
     MKNQDKKNGA AKQSNPKSSP GQPEAGPEGA QERPSQAAPA VEAEGPGSSQ APRKPEGAQA
     RTAQSGALRD VSEELSRQLE DILSTYCVDN NQGGPGEDGA QGEPAEPEDA EKSRTYVARN
     GEPEPTPVVN GEKEPSKGDP NTEEIRQSDE VGDRDHRRPQ EKKKAKGLGK EITLLMQTLN
     TLSTPEEKLA ALCKKYAELL EEHRNSQKQM KLLQKKQSQL VQEKDHLRGE HSKAVLARSK
     LESLCRELQR HNRSLKEEGV QRAREEEEKR KEVTSHFQVT LNDIQLQMEQ HNERNSKLRQ
     ENMELAERLK KLIEQYELRE EHIDKVFKHK DLQQQLVDAK LQQAQEMLKE AEERHQREKD
     FLLKEAVESQ RMCELMKQQE THLKQQLALY TEKFEEFQNT LSKSSEVFTT FKQEMEKMTK
     KIKKLEKETT MYRSRWESSN KALLEMAEEK TVRDKELEGL QVKIQRLEKL CRALQTERND
     LNKRVQDLSA GGQGSLTDSG PERRPEGPGA QAPSSPRVTE APCYPGAPST EASGQTGPQE
     PTSARA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024